Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1(G93A) mouse model of ALS.
- DOI
- 10.1016/j.neurot.2026.e01062
- Published
- 2026 Sep
- Container
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neurot.2026.e01062,
title = {Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1(G93A) mouse model of ALS.},
author = {Fernández-Beltrán LC and García-Toledo I and Javaloyes García K and Jiménez-Coca I and Jiménez-Rodríguez J and Fernández-Bernal A and Godoy-Corchuelo JM and Portero-Otín M and Corrochano S},
year = {2026},
journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
doi = {10.1016/j.neurot.2026.e01062},
url = {https://doi.org/10.1016/j.neurot.2026.e01062}
}RIS
TY - JOUR TI - Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1(G93A) mouse model of ALS. AU - Fernández-Beltrán LC AU - García-Toledo I AU - Javaloyes García K AU - Jiménez-Coca I AU - Jiménez-Rodríguez J AU - Fernández-Bernal A AU - Godoy-Corchuelo JM AU - Portero-Otín M AU - Corrochano S PY - 2026 JO - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics DO - 10.1016/j.neurot.2026.e01062 UR - https://doi.org/10.1016/j.neurot.2026.e01062 ER -
APA
LC, F., I, G., K, J. G., I, J., J, J., A, F., JM, G., M, P., & S, C. (2026). Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1(G93A) mouse model of ALS.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2026.e01062
Source records
- pubmed · retrieved 2026-09-25T09:15:37.735Z